Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

385301

	registered interest
	date	24/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government why the national waiting time criterion for referral to hepatitis C treatment is 18 weeks whereas the national waiting time criterion for referral to specialist services for HIV treatment is two weeks.
	tabling member printed	Baroness Masham of Ilton
	uin	HL784
	answer	answer is ministerial correction date of answer 08/07/2015 answer text <p><del class="ministerial">NHS England and Public Health England (PHE) are working alongside a coalition of other organisations and patient groups to draft a framework for hepatitis C improvement. This hepatitis C improvement framework will set high level aims for the public health system towards elimination of hepatitis C related liver disease as a significant public health concern.</del></p><p> </p><p> </p><p> </p><p><del class="ministerial">The hepatitis C improvement framework will be referred to in PHE’s liver disease framework.</del></p><p> </p><p><ins class="ministerial">Timing for access to care or treatments for all NHS England service specifications or policies is based on an assessment of the evidence for clinical effectiveness, cost effectiveness and affordability.</ins></p><p> </p><p> </p> answering member printed Lord Prior of Brampton question first answered 08/07/2015 13:53:15 question first ministerially corrected 08/07/2015 14:59:37 answering member 127 label Biography information for Lord Prior of Brampton previous answer version 12907 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1850 label Biography information for Baroness Masham of Ilton

909643

	registered interest
	date	22/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they intend to ensure that currently under-served groups, such as people who inject drugs and those in prisons, are included in the elimination plan for hepatitis C.
	tabling member printed	Baroness Masham of Ilton
	uin	HL8138
	answer	answer is ministerial correction date of answer 05/06/2018 answer text <p>A variety of initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence.</p><p>As part of health services commissioned for those in detained settings, NHS England has rolled out an ambitious Opt-Out Blood Borne Viruses (BBV) testing programme. The key aim is to improve uptake rates for hepatitis C testing by the introduction of good practice for ‘meaningful offer’ of BBV testing across the adult prison estate. In this programme appropriately trained staff offer prisoners a BBV testing on an opt-out basis within 72 hours of reception in accordance with published national guidance, with referral to specialists for assessment for treatment (which can be delivered in prison or on release). This programme has been embedded across the secure estate from April 2018.</p><p>The creation of 22 operational delivery networks in England to drive improvements in treatment in local areas is intended to give all patients the access to the treatment they need regardless of where they live.</p> answering member printed Lord O'Shaughnessy question first answered 05/06/2018 15:59:48 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1850 label Biography information for Baroness Masham of Ilton

909642

	registered interest
	date	22/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that the NHS England target of eliminating hepatitis C by 2025 is reached.
	tabling member printed	Baroness Masham of Ilton
	uin	HL8137
	answer	answer is ministerial correction date of answer 05/06/2018 answer text <p>NHS England has embarked on a new procurement exercise that invites industry to support the plans to tackle hepatitis C as part of a longer term drug procurement contract. This procurement exercise was officially launched in March 2018. The conclusion of assessment of proposals is planned for September 2018 and NHS England anticipates the new procurement approach will be implemented from 1 October 2018. The aim of the strategic procurement is to accelerate whole systems action to reduce hepatitis C prevalence and incidence. If successful, the ambition is to support the elimination of hepatitis C as a public health threat earlier than the World Health Organization (WHO) goal of 2030 and as soon as 2025.</p><p>Public Health England who lead on hepatitis C surveillance will ensure that achievements against the WHO targets in England are tracked. The National Strategic Group for Viral Hepatitis will continue to bring together stakeholders to discuss and share individual and collective actions underway to contribute to these goals.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8136 question first answered 05/06/2018 15:58:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1850 label Biography information for Baroness Masham of Ilton

909641

	registered interest
	date	22/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they intend to take to ensure that there is a comprehensive and measurable hepatitis C elimination plan in place, with clear lines of accountability, to achieve the NHS England 2025 elimination goal.
	tabling member printed	Baroness Masham of Ilton
	uin	HL8136
	answer	answer is ministerial correction date of answer 05/06/2018 answer text <p>NHS England has embarked on a new procurement exercise that invites industry to support the plans to tackle hepatitis C as part of a longer term drug procurement contract. This procurement exercise was officially launched in March 2018. The conclusion of assessment of proposals is planned for September 2018 and NHS England anticipates the new procurement approach will be implemented from 1 October 2018. The aim of the strategic procurement is to accelerate whole systems action to reduce hepatitis C prevalence and incidence. If successful, the ambition is to support the elimination of hepatitis C as a public health threat earlier than the World Health Organization (WHO) goal of 2030 and as soon as 2025.</p><p>Public Health England who lead on hepatitis C surveillance will ensure that achievements against the WHO targets in England are tracked. The National Strategic Group for Viral Hepatitis will continue to bring together stakeholders to discuss and share individual and collective actions underway to contribute to these goals.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8137 question first answered 05/06/2018 15:58:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1850 label Biography information for Baroness Masham of Ilton

512780

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when NHS England expects to publish its operational framework for hepatitis C.
	tabling member printed	Lord Mancroft
	uin	HL7669
	answer	answer is ministerial correction date of answer 27/04/2016 answer text <p>NHS England has already published its planning approach to implement National Institute for Health and Care Excellence (NICE) recommended treatment during 2016/17. NHS England has committed to produce an operational framework for hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England. The publication date for the document has not been set but we anticipate work to continue during the late spring and early summer.</p><p> </p><p>NICE Technology Appraisals (TA) 363, 364 and 365 require Operational Delivery Networks to prioritise treatment for patients with the highest unmet clinical need. The National Health Service commitment to 10,000 treatments in 2016/17 reflects the multi-year modelling used by NICE and published in conjunction with the recommendations for TA 364. The NICE recommendations note that treatment decisions are influenced by clinical characteristics such as level of liver damage, genotype, treatment history and comorbidities. The recommendations also record the advice of clinical experts to the committee that a realistic estimate of patients accessing treatment each year is between 7-10,000.</p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7670 question first answered 27/04/2016 12:41:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1833 label Biography information for Lord Mancroft

484879

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.
	tabling member printed	Lord Mancroft
	uin	HL7382
	answer	answer is ministerial correction date of answer 04/04/2016 answer text <p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7380 HL7381 question first answered 04/04/2016 15:16:52 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1833 label Biography information for Lord Mancroft

484878

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether plans to introduce a hepatitis C improvement framework have been abandoned and, if so, why.
	tabling member printed	Lord Mancroft
	uin	HL7381
	answer	answer is ministerial correction date of answer 04/04/2016 answer text <p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7380 HL7382 question first answered 04/04/2016 15:16:52 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1833 label Biography information for Lord Mancroft

484877

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what plans they have to review their hepatitis C strategy in the light of other European countries' strategies for tackling hepatitis C.
	tabling member printed	Lord Mancroft
	uin	HL7380
	answer	answer is ministerial correction date of answer 04/04/2016 answer text <p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7381 HL7382 question first answered 04/04/2016 15:16:52 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1833 label Biography information for Lord Mancroft

484874

	registered interest
	date	23/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how many hepatitis C patients NHS England is planning to treat in 2016–17.
	tabling member printed	Lord Mancroft
	uin	HL7377
	answer	answer is ministerial correction date of answer 04/04/2016 answer text <p>NHS England is planning to treat 10,000 patients with chronic hepatitis C in 2016/2017.</p> answering member printed Lord Prior of Brampton question first answered 04/04/2016 15:12:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1833 label Biography information for Lord Mancroft

483280

	registered interest
	date	21/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what new steps they are taking to improve identification and testing of people potentially infected with hepatitis C as part of a coherent approach to treatment of the population at large.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7204
	answer	answer is ministerial correction date of answer 04/04/2016 answer text <p>The United Kingdom Government takes the issue of prevention, diagnosis and treatment of hepatitis C very seriously. Public Health England (PHE) and NHS England continue working together with key stakeholders to establish a strategic approach to tackle hepatitis C, including monitoring treatment access and uptake, as well as establishing Operation Delivery Networks (ODNs).</p><p>NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.</p><p>PHE is working together with NHS England and the National Offender Management Service to improve coverage of blood borne virus testing for people in prisons through implementation of opt-out testing.</p><p>PHE has also commissioned the Royal College of General Practitioners (RCGP) <em>Certificate in the Detection, Diagnosis and Management of Hepatitis B and C in Primary Care</em> to help raise awareness in primary care and among other professionals working with groups at high risk of chronic viral hepatitis infection. To supplement this, a new RCGP course was launched in April 2015, <em>Hepatitis C: Enhancing Prevention, Testing and Care</em> which comprises four lessons: understanding hepatitis C; preventing transmission; testing and diagnosis; and treatment and care.</p><p> </p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7203 question first answered 04/04/2016 13:44:50 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath